GENEVA, July 3 -- ANTIGER THERAPEUTICS, INC. (4340 Duncan Ave. Suite 284St. Louis, Missouri 63110) filed a patent application (PCT/US2024/061476) for "CLASS II HLA WITH INTER-CHAIN DISULFIDE BOND" on Dec 20, 2024. With publication no. WO/2025/137580, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUO, Hongjie (4340 Duncan Ave. Suite 284St. Louis, Missouri 63110), LIU, Chang (4340 Duncan Ave. Suite 284St. Louis, Missouri 63110)

Abstract: The present disclosure provides modified HLA molecules comprising an Alpha chain a...